Is HCMV a tumor promoter?

Virus Res. 2011 May;157(2):193-203. doi: 10.1016/j.virusres.2010.10.026. Epub 2010 Oct 29.

Abstract

Human cytomegalovirus (HCMV) is a beta-herpesvirus that causes persistent infection in humans and can cause severe disease in fetuses and immunocompromised individuals. Although HCMV is not currently causally implicated in human cancer, emerging evidence suggests that HCMV infection and expression may be specifically associated with human malignancies including malignant glioma, colon, and prostate cancer. In addition, multiple investigators have demonstrated that HCMV can dysregulate signaling pathways involved in initiation and promotion of malignancy, including tumor suppressor, mitogenic signaling, inflammatory, immune regulation, angiogenesis and invasion, and epigenetic mechanisms. This review highlights some of the recent evidence that HCMV might play a role in modulating the tumor microenvironment as well as in the initiation and promotion of tumor cells themselves.

Publication types

  • Review

MeSH terms

  • Angiogenesis Inducing Agents
  • Apoptosis
  • Cell Cycle
  • Cytomegalovirus / genetics
  • Cytomegalovirus / pathogenicity*
  • Cytomegalovirus Infections / genetics
  • Cytomegalovirus Infections / pathology
  • DNA Repair
  • Glycolysis / physiology
  • Humans
  • Immune Evasion
  • Inflammation
  • Neoplasms / immunology
  • Neoplasms / virology*
  • Neovascularization, Pathologic
  • Oncogene Proteins / biosynthesis
  • Oncogenic Viruses*
  • Receptors, Chemokine / metabolism
  • Retinoblastoma Protein / metabolism
  • Tumor Escape
  • Tumor Suppressor Protein p53 / metabolism
  • Viral Proteins / metabolism

Substances

  • Angiogenesis Inducing Agents
  • Oncogene Proteins
  • Receptors, Chemokine
  • Retinoblastoma Protein
  • Tumor Suppressor Protein p53
  • US28 receptor, Cytomegalovirus
  • Viral Proteins